VERACYTE, INC. Research and Development Expense
VERACYTE, INC. (VCYT) reported Research and Development Expense of $29.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-31
- VERACYTE, INC. research and development expense for the quarter ending 2026-06-30 was $29.44M, a 81.03% increase year-over-year.
- VERACYTE, INC. research and development expense for the quarter ending 2026-03-31 was $27.10M, a 52.92% increase year-over-year.
- VERACYTE, INC. research and development expense for the quarter ending 2025-12-31 was $20.85M, a 8.08% increase year-over-year.
- VERACYTE, INC. research and development expense for the quarter ending 2025-09-30 was $15.98M, a 9.06% decline year-over-year.
- VERACYTE, INC. research and development expense for fiscal 2025 was $70.81M, a 2.19% increase from fiscal 2024.
- VERACYTE, INC. research and development expense for fiscal 2024 was $69.29M, a 20.92% increase from fiscal 2023.
- VERACYTE, INC. research and development expense for fiscal 2023 was $57.30M, a 41.13% increase from fiscal 2022.
- VERACYTE, INC. research and development expense for fiscal 2022 was $40.60M, a 36.06% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.44M 10-Q · filed 2026-07-31 | $56.54M 10-Q · filed 2026-07-31 | $77.39M derived: sum of 3 quarters · filed 2026-07-31 | $93.37M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $27.10M 10-Q · filed 2026-05-06 | $47.95M derived: sum of 2 quarters · filed 2026-05-06 | $63.93M derived: sum of 3 quarters · filed 2026-05-06 | $80.19M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $20.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.83M derived: sum of 2 quarters · filed 2026-02-26 | $53.09M derived: sum of 3 quarters · filed 2026-07-31 | $70.81M 10-K · filed 2026-02-26 |
| 2025-09-30 | $15.98M 10-Q · filed 2025-11-05 | $32.24M derived: sum of 2 quarters · filed 2026-07-31 | $49.97M 10-Q · filed 2025-11-05 | $69.25M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $16.26M 10-Q · filed 2026-07-31 | $33.98M 10-Q · filed 2026-07-31 | $53.27M derived: sum of 3 quarters · filed 2026-07-31 | $70.85M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $17.72M 10-Q · filed 2026-05-06 | $37.01M derived: sum of 2 quarters · filed 2026-05-06 | $54.58M derived: sum of 3 quarters · filed 2026-05-06 | $71.05M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $19.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.86M derived: sum of 2 quarters · filed 2026-02-26 | $53.33M derived: sum of 3 quarters · filed 2026-02-26 | $69.29M 10-K · filed 2026-02-26 |
| 2024-09-30 | $17.57M 10-Q · filed 2025-11-05 | $34.04M derived: sum of 2 quarters · filed 2025-11-05 | $50.00M 10-Q · filed 2025-11-05 | $68.68M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $16.46M 10-Q · filed 2025-08-07 | $32.43M 10-Q · filed 2025-08-07 | $51.10M derived: sum of 3 quarters · filed 2026-02-26 | $64.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $15.96M 10-Q · filed 2025-05-08 | $34.64M derived: sum of 2 quarters · filed 2026-02-26 | $47.96M derived: sum of 3 quarters · filed 2026-02-26 | $60.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $18.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.00M derived: sum of 2 quarters · filed 2026-02-26 | $44.54M derived: sum of 3 quarters · filed 2026-02-26 | $57.30M 10-K · filed 2026-02-26 |
| 2023-09-30 | $13.32M 10-Q · filed 2024-11-07 | $25.86M derived: sum of 2 quarters · filed 2024-11-07 | $38.63M 10-Q · filed 2024-11-07 | $49.92M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $12.54M 10-Q · filed 2024-08-07 | $25.31M 10-Q · filed 2024-08-07 | $36.60M derived: sum of 3 quarters · filed 2025-02-28 | $47.37M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $12.77M 10-Q · filed 2024-05-08 | $24.06M derived: sum of 2 quarters · filed 2025-02-28 | $34.83M derived: sum of 3 quarters · filed 2025-02-28 | $44.21M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $11.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $22.06M derived: sum of 2 quarters · filed 2025-02-28 | $31.44M derived: sum of 3 quarters · filed 2025-02-28 | $40.60M 10-K · filed 2025-02-28 |
| 2022-09-30 | $10.77M 10-Q · filed 2023-11-08 | $20.15M derived: sum of 2 quarters · filed 2023-11-08 | $29.32M 10-Q · filed 2023-11-08 | $39.57M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $9.38M 10-Q · filed 2023-08-09 | $18.54M 10-Q · filed 2023-08-09 | $28.80M derived: sum of 3 quarters · filed 2024-02-29 | $36.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $9.17M 10-Q · filed 2023-05-05 | $19.42M derived: sum of 2 quarters · filed 2024-02-29 | $27.42M derived: sum of 3 quarters · filed 2024-02-29 | $33.67M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $18.26M derived: sum of 2 quarters · filed 2024-02-29 | $24.51M derived: sum of 3 quarters · filed 2024-02-29 | $29.84M 10-K · filed 2024-02-29 |
| 2021-09-30 | $8.01M 10-Q · filed 2022-11-03 | $14.26M derived: sum of 2 quarters · filed 2022-11-03 | $19.59M 10-Q · filed 2022-11-03 | $24.18M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.25M 10-Q · filed 2022-08-03 | $11.59M 10-Q · filed 2022-08-03 | $16.17M derived: sum of 3 quarters · filed 2023-03-01 | $20.21M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $5.34M 10-Q · filed 2022-05-04 | $9.92M derived: sum of 2 quarters · filed 2023-03-01 | $13.96M derived: sum of 3 quarters · filed 2023-03-01 | $18.13M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.63M derived: sum of 2 quarters · filed 2023-03-01 | $12.80M derived: sum of 3 quarters · filed 2023-03-01 | $17.20M 10-K · filed 2023-03-01 |
| 2020-09-30 | $4.04M 10-Q · filed 2021-11-09 | $8.21M derived: sum of 2 quarters · filed 2021-11-09 | $12.62M 10-Q · filed 2021-11-09 | $17.06M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $4.17M 10-Q · filed 2021-07-29 | $8.58M 10-Q · filed 2021-07-29 | $13.02M derived: sum of 3 quarters · filed 2022-02-28 | $16.66M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $4.41M 10-Q · filed 2021-05-10 | $8.85M derived: sum of 2 quarters · filed 2022-02-28 | $12.49M derived: sum of 3 quarters · filed 2022-02-28 | $15.82M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $8.09M derived: sum of 2 quarters · filed 2022-02-28 | $11.42M derived: sum of 3 quarters · filed 2022-02-28 | $14.85M 10-K · filed 2022-02-28 |
| 2019-09-30 | $3.64M 10-Q · filed 2020-11-02 | $6.97M derived: sum of 2 quarters · filed 2020-11-02 | $10.41M 10-Q · filed 2020-11-02 | $13.53M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $3.33M 10-Q · filed 2020-07-30 | $6.76M 10-Q · filed 2020-07-30 | $9.89M derived: sum of 3 quarters · filed 2021-02-22 | $13.31M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $3.44M 10-Q · filed 2020-05-06 | $6.56M derived: sum of 2 quarters · filed 2021-02-22 | $9.98M derived: sum of 3 quarters · filed 2021-02-22 | $14.58M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $6.54M derived: sum of 2 quarters · filed 2021-02-22 | $11.14M derived: sum of 3 quarters · filed 2021-02-22 | $14.82M 10-K · filed 2021-02-22 |
| 2018-09-30 | $3.42M 10-Q · filed 2019-10-22 | $8.02M derived: sum of 2 quarters · filed 2019-10-22 | $11.70M 10-Q · filed 2019-10-22 | $14.90M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.60M 10-Q · filed 2019-07-30 | $8.28M 10-Q · filed 2019-07-30 | $11.48M derived: sum of 3 quarters · filed 2020-02-25 | $14.52M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $3.67M 10-Q · filed 2019-04-30 | $6.88M derived: sum of 2 quarters · filed 2020-02-25 | $9.92M derived: sum of 3 quarters · filed 2020-02-25 | $13.53M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.25M derived: sum of 2 quarters · filed 2020-02-25 | $9.85M derived: sum of 3 quarters · filed 2020-02-25 | $13.88M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.05M 10-Q · filed 2018-10-29 | $6.65M derived: sum of 2 quarters · filed 2018-10-29 | $10.68M 10-Q · filed 2018-10-29 | $14.27M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $3.60M 10-Q · filed 2018-07-23 | $7.63M 10-Q · filed 2018-07-23 | $11.22M derived: sum of 3 quarters · filed 2019-02-25 | $15.23M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $4.03M 10-Q · filed 2018-05-01 | $7.62M derived: sum of 2 quarters · filed 2019-02-25 | $11.63M derived: sum of 3 quarters · filed 2019-02-25 | $15.89M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $7.60M derived: sum of 2 quarters · filed 2019-02-25 | $11.86M derived: sum of 3 quarters · filed 2019-02-25 | $15.32M 10-K · filed 2019-02-25 |
| 2016-09-30 | $4.01M 10-Q · filed 2017-11-07 | $8.27M derived: sum of 2 quarters · filed 2017-11-07 | $11.73M 10-Q · filed 2017-11-07 | $15.08M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $4.27M 10-Q · filed 2017-07-31 | $7.73M 10-Q · filed 2017-07-31 | $11.07M derived: sum of 3 quarters · filed 2018-02-27 | $14.63M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $3.46M 10-Q · filed 2017-05-03 | $6.80M derived: sum of 2 quarters · filed 2018-02-27 | $10.37M derived: sum of 3 quarters · filed 2018-02-27 | $13.47M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $6.91M derived: sum of 2 quarters · filed 2018-02-27 | $10.01M derived: sum of 3 quarters · filed 2018-02-27 | $12.80M 10-K · filed 2018-02-27 |
| 2015-09-30 | $3.56M 10-Q · filed 2016-11-03 | $6.67M derived: sum of 2 quarters · filed 2016-11-03 | $9.45M 10-Q · filed 2016-11-03 | $12.65M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $3.10M 10-Q · filed 2016-08-03 | $5.89M 10-Q · filed 2016-08-03 | $9.09M derived: sum of 3 quarters · filed 2017-03-01 | $11.32M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.79M 10-Q · filed 2016-05-05 | $5.99M derived: sum of 2 quarters · filed 2017-03-01 | $8.22M derived: sum of 3 quarters · filed 2017-03-01 | $10.46M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.43M derived: sum of 2 quarters · filed 2017-03-01 | $7.68M derived: sum of 3 quarters · filed 2017-03-01 | $9.80M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.23M 10-Q · filed 2015-11-05 | $4.48M derived: sum of 2 quarters · filed 2015-11-05 | $6.60M 10-Q · filed 2015-11-05 | $8.47M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $2.24M 10-Q · filed 2015-08-13 | $4.37M 10-Q · filed 2015-08-13 | $6.24M derived: sum of 3 quarters · filed 2016-03-14 | $8.27M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $2.13M 10-Q · filed 2015-05-15 | $4.00M derived: sum of 2 quarters · filed 2016-03-14 | $6.02M derived: sum of 3 quarters · filed 2016-03-14 | $7.93M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $3.90M derived: sum of 2 quarters · filed 2016-03-14 | $5.80M derived: sum of 3 quarters · filed 2016-03-14 | $7.81M 10-K · filed 2016-03-14 |
| 2013-09-30 | $2.03M 10-Q · filed 2014-11-13 | $3.93M derived: sum of 2 quarters · filed 2014-11-13 | $5.94M 10-Q · filed 2014-11-13 | $7.66M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-06-30 | $1.90M 10-Q · filed 2014-08-14 | $3.91M 10-Q · filed 2014-08-14 | $5.63M derived: sum of 3 quarters · filed 2015-03-25 | $7.36M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-03-31 | $2.01M 10-Q · filed 2014-05-09 | $3.73M derived: sum of 2 quarters · filed 2015-03-25 | $5.46M derived: sum of 3 quarters · filed 2015-03-25 | |
| 2012-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $3.45M derived: sum of 2 quarters · filed 2015-03-25 | $6.61M 10-K · filed 2015-03-25 | |
| 2012-09-30 | $1.73M 10-Q · filed 2013-11-25 | $4.89M 10-Q · filed 2013-11-25 | ||
| 2011-12-31 | $6.68M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |